Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome

This publication has 15 references indexed in Scilit:

• Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey
  Circulation, 2004
• Metabolic Syndrome and Vascular Disease
  Circulation, 2004
• Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
  Circulation, 2003
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)
  Published by Elsevier ,2003
• Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome
  The American Journal of Cardiology, 2003
• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
  The Lancet, 2003
• Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
  JAMA, 2003
• The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
  JAMA, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Waist circumference as a measure for indicating need for weight management
  BMJ, 1995